Loading dose vitamin D3 improves vitamin D insufficiency in adults undergoing hematopoietic stem cell transplantation: A randomized controlled trial
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0284644 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2023. Verfasst von Ni Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, Leukemia Bone Marrow Transplant Program of British Columbia, University of British Columbia, Vancouve…. Hauptthemen laut MEDLINE: Vitamin D Deficiency, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Allogeneic hematopoietic stem cell transplant (aHSCT) patients are well known to be at high risk of vitamin D (vit D) deficiency. This study assessed whether a loading dose (100,000 IU) of vitamin D 3 pre-aHSCT could effectively achieve and maintain sufficient post-transplant vit D levels (serum total 25 hydroxy vitamin D (25(OH)D) ≥ 75nmol/L). Dual-energy X-ray absorptiometry (DXA) was also conducted for bone health evaluation. 74 patients were enrolled and randomly assigned, in a 1:1 ratio, either to the high vit D group (single loading dose (100,000 IU) plus 2,000 IU vit D 3 daily) or the control group (2,000 IU vit D 3 daily). Vit D levels were measured at three time points (baseline, day 30 and day 100 post-aHSCT). At baseline, fewer than 50% patients had a sufficient 25(OH)D (control: 42.9%; high vit D: 43.6%). The proportion of patients with sufficient 25(OH)D (nmol/L) was increased at day 30 and day 100, with a trend of higher proportion in the high vit D group at day 30 (high vit D vs. control: 89.7% vs. 74.3%, p = 0.08). The increased 25(OH)D was significantly higher in the high vit D group at day 30 (high vit D vs. control: 29±25.2 vs. 14 ±21.9, p = 0.01). Insufficient vit D level before transplant (baseline) was an independent risk factor for vit D insufficiency (serum 25(OH)D < 75nmol/L) post-aHSCT (OR = 4.16, p = 0.03). DXA suggested significant bone loss for total hip in both groups, and in the femoral neck for the control group only. In conclusion, single loading dose vitamin D 3 significantly increased total 25(OH)D levels at day 30 post-transplant, and the intervention was especially beneficial for patients with baseline vit D insufficiency. We acknowledge that the primary outcome at day 100 post-aHSCT indicating superiority of loading dose versus daily dose supplementation was not met.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Department of Medicine, Leukemia Bone Marrow Transplant Program of British Columbia, University of British Columbia, Vancouver, Canada.
- Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Rangsit Campus, Pathumthani, Thailand.
- Division of Endocrinology, Department of Medicine, University of British Columbia, Vancouver, Canada.
ORCID-Profile: Ni Bai, Wasithep Limvorapitak
Zitieren
APA
Bai, N., Lee, K., Limvorapitak, W., Liu, E., Kendler, D., Broady, R., & White, J. (2023). Loading dose vitamin D3 improves vitamin D insufficiency in adults undergoing hematopoietic stem cell transplantation: A randomized controlled trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0284644
Vancouver
Bai N, Lee K, Limvorapitak W, Liu E, Kendler D, Broady R, et al. Loading dose vitamin D3 improves vitamin D insufficiency in adults undergoing hematopoietic stem cell transplantation: A randomized controlled trial. PLOS ONE. 2023. doi:10.1371/journal.pone.0284644
BibTeX
@article{Bai2023,
author = {Bai, Ni and Lee, Karen and Limvorapitak, Wasithep and Liu, Emily and Kendler, David and Broady, Raewyn and White, Jennifer},
title = {Loading dose vitamin D3 improves vitamin D insufficiency in adults undergoing hematopoietic stem cell transplantation: A randomized controlled trial},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0284644}
}
EUVIMED